FDA Adverse Event Malfunction Summary report: N

ONCOLOGY KIT W/SPINNING SPIROS, C-CLIP, RED CAP

MDR report key: 11723468 · Received April 26, 2021

Report

Report Number
9617594-2021-00135
Event Type
Malfunction
Date Received
April 26, 2021
Date of Event
February 1, 2021
Report Date
March 30, 2021
Manufacturer
ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.
Product Code
FPA
UDI-DI
00887709079243
PMA / PMN Number
K081361
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 0

A PHOTOGRAPH OF THE PRODUCT PACKAGING WAS PROVIDED AND EVALUATED. THE SPIROS WAS NOT VISIBLE IN THE IMAGE. NO PRODUCT SAMPLES WERE RETURNED FOR INVESTIGATION. THE DHR FOR LOT NUMBER 5030925 WAS REVIEWED AND THERE WERE NO RELEVANT NON-CONFORMANCES FOUND THAT WOULD HAVE CONTRIBUTED TO THE REPORTED COMPLAINT. THE REPORTED COMPLAINT CANNOT BE CONFIRMED BASED ON THE INFORMATION THAT HAS BEEN PROVIDED.

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. WITHOUT THE RETURN OF THE SAMPLE A COMPREHENSIVE FAILURE INVESTIGATION CANNOT BE PERFORMED, AND A CAUSE CANNOT BE DETERMINED.

Description of Event or Problem · 1

THE EVENT INVOLVED ONCOLOGY KIT W/SPINNING SPIROS®, C-CLIP, RED CAP WHICH LEAKED UNSPECIFIED CHEMOTHERAPY ON PATIENT OR HEALTHCARE PROVIDER. THE DEVICE HAD BEEN INSPECTED PRIOR TO USE AND ALL PARTS WERE IN PLACE APPROPRIATELY. NO HOLE, CUT, TEARS OR ANY DEFECT NOTED; IT WAS ALL OVER THE CLOSED BAG SO THE USER COULD NOT FULLY MANIPULATE. THE CHEMO SPILL WAS CLEANED UP PER FACILITY PROTOCOL. THERE WAS NO BLOOD LOSS OR BLEED BACK. THE DRUG WAS REPLACED AND NO FURTHER ISSUES WERE REPORTED. THERE WAS PATIENT INVOLVEMENT, HOWEVER, THERE WAS NO ADVERSE OUTCOME AS A CONSEQUENCE OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
623491 ONCOLOGY KIT W/SPINNING SPIROS, C-CLIP, RED CAP SET, ADMINISTRATION, INTRAVASCULAR FPA ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. 5030925 00887709079243

Patients

Seq Age Sex Outcome Treatment
1 UNSPECIFIED CHEMOTHERAPY, MFR UNK